CD36 and cancer: Almost twenty cancer types revealed dysregulated expression of CD36, analyzed by TIMER2 and GEPIA2, including UCEC, THCA, STAD, SKCM, READ, PRAD, PAAD, LUSC, LUAD, LIHC, LAML, KIRP, KIRC, HNSC, GBM, COAD, CHOL, BRCA, and BLCA (Fig. 1A–B).